STATEMENT 2026

Ferring and RedHill Biopharma enter strategic partnership for Rebyota® and Clenpiq®

By celia in STATEMENT 2026 on 01 September 2026

Ferring Pharmaceuticals successfully launches its fourth Swiss Franc Bond offering for CHF 250 million

By celia in STATEMENT 2026 on 01 July 2026

Ferring announces changes to Board of Directors and Executive Committee

By celia in STATEMENT 2026 on 16 February 2026

Ferring Pharmaceuticals climate targets validated by Science Based Targets initiative

By celia in STATEMENT 2026 on 15 January 2026